China SXT Pharmaceuticals (SXTC) Non-Current Assets: 2018-2025
- China SXT Pharmaceuticals' Non-Current Assets fell 96.55% to $310,889 in Q3 2025 from the same period last year, while for Sep 2025 it was $310,889, marking a year-over-year decrease of 96.55%. This contributed to the annual value of $367,017 for FY2025, which is 95.87% down from last year.
- Per China SXT Pharmaceuticals' latest filing, its Non-Current Assets stood at $310,889 for Q3 2025, which was down 15.29% from $367,017 recorded in Q1 2025.
- In the past 5 years, China SXT Pharmaceuticals' Non-Current Assets ranged from a high of $11.3 million in Q1 2021 and a low of $310,889 during Q3 2025.
- Its 3-year average for Non-Current Assets is $5.0 million, with a median of $5.0 million in 2023.
- Its Non-Current Assets has fluctuated over the past 5 years, first surged by 724.50% in 2024, then crashed by 96.55% in 2025.
- Quarterly analysis of 5 years shows China SXT Pharmaceuticals' Non-Current Assets stood at $11.0 million in 2021, then decreased by 10.79% to $9.8 million in 2022, then crashed by 88.87% to $1.1 million in 2023, then skyrocketed by 724.50% to $9.0 million in 2024, then plummeted by 96.55% to $310,889 in 2025.
- Its Non-Current Assets was $310,889 in Q3 2025, compared to $367,017 in Q1 2025 and $9.0 million in Q3 2024.
